June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
A Novel CRISPR-based Series of Retinitis Pigmentosa Models in Zebrafish
Author Affiliations & Notes
  • Liyun Zhang
    Johns Hopkins School of Medicine, Ellicott City, Maryland, United States
  • Emilie Cheng
    Johns Hopkins School of Medicine, Ellicott City, Maryland, United States
  • Jie Dong
    Capital Medical University, China
  • naveena Murugan
    Johns Hopkins School of Medicine, Ellicott City, Maryland, United States
  • wuhong pei
    National Human Genome Research Institute, Maryland, United States
  • Lisha Xu
    National Human Genome Research Institute, Maryland, United States
  • Shawn Burgess
    National Human Genome Research Institute, Maryland, United States
  • Meera Saxena
    Johns Hopkins School of Medicine, Ellicott City, Maryland, United States
  • Jeff S Mumm
    Johns Hopkins School of Medicine, Ellicott City, Maryland, United States
  • Footnotes
    Commercial Relationships   Liyun Zhang, None; Emilie Cheng, None; Jie Dong, None; naveena Murugan, None; wuhong pei, None; Lisha Xu, None; Shawn Burgess, None; Meera Saxena, None; Jeff Mumm, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 664. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Liyun Zhang, Emilie Cheng, Jie Dong, naveena Murugan, wuhong pei, Lisha Xu, Shawn Burgess, Meera Saxena, Jeff S Mumm; A Novel CRISPR-based Series of Retinitis Pigmentosa Models in Zebrafish. Invest. Ophthalmol. Vis. Sci. 2020;61(7):664.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinitis pigmentosa (RP) is a hereditary retinal degeneration characterized by progressive rod photoreceptor death followed by cone cell loss. Although over 70 genes have been reported to be responsible for RP, the underlying disease mechanisms are largely unclear. Moreover, no therapy can substantially treat most patients. To better understand RP-causative gene function and seek effective treatment, we utilized CRISPR to disrupt zebrafish homologs of major human RP-linked genes, and generated a series of novel genetic mutant models of RP that are highly amenable to small molecule screening for new neuroprotectants.

Methods : In non-syndromic RP, the most common disease-causing genes are RHO, PDE6A and PDE6B. In this study, zebrafish homologs (rho, pde6a, and pde6b) were disrupted by co-injecting Cas9 mRNA with one or two guide RNAs targeting the 5’-end of each gene into zebrafish embryos at one cell stage. Mutant founders identified by fluorescence PCR and sequencing were crossed to a transgenic line in which rod photoreceptors are labeled with yellow fluorescence protein (YFP). YFP-expressing heterozygous progeny carrying frameshift mutations predicted to interrupt gene function were propagated and pair bred. Collected embryos underwent qualitative visual screen and confocal imaging, as well as an automated YFP quantification assay using a microplate reader from 4 to 8 days post-fertilization (dpf). At 8 dpf, larval tails were collected for genotyping and heads for immunofluorescence assays.

Results : Frameshift mutations were identified in rho, pde6a, and pde6b genes. The selected mutant alleles (rhoJH600E, rhoJH600F, pde6aJH602I, and pde6bJH603E) were further characterized. Phenotyping/genotyping showed that reductions of rod-YFP expression were highly associated with either heterozygous or homozygous mutations. Confocal intravital imaging confirmed rod cell loss in mutants. Time-series YFP quantification displayed a range of rod cell loss with varying severity and temporal progression. Rod marker 1d1 staining verified rod photoreceptor degeneration, but cone marker zpr1 staining showed no obvious cone cell loss out to 8 dpf.

Conclusions : We successfully generated a series of novel zebrafish RP models, exhibiting varying severity of rod photoreceptor degeneration. These genetic mutant models will be valuable for mechanistic studies of mutation effects and in vivo reporter-based phenotypic drug discovery.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×